Becton Can't Dodge Rival Syringe Maker's Antitrust Claims

By Jeremy Heallen (August 19, 2013, 5:13 PM EDT) -- Syringe maker Becton Dickinson and Co. was unable to duck antitrust and false advertising claims brought by rival Retractable Technologies Inc., as a Texas federal judge ruled Monday that sufficient proof existed to send the case to trial next month.

In denying a pair of motions seeking summary judgment on the claims, U.S. District Judge Leonard Davis adopted the March 14 recommendations of Magistrate Judge Roy S. Payne, who found evidentiary support for Retractable's allegations that BD used bundling, loyalty discounts and tying arrangements with clinics to maintain a monopoly on the syringe industry for more than five decades. The decision...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!